Results 181 to 190 of about 27,289 (199)

A meta-analysis of add-on use of spironolactone in patients with resistant hypertension

International Journal of Cardiology, 2017
Di Zhao, Pingshuan Dong
exaly  

Spironolactone

Reactions Weekly, 1995
openaire   +2 more sources

Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use

International Journal of Pharmaceutics, 2006
C Charcosset
exaly  

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

Lancet, The, 2015
Thomas Macdonald, J Kennedy Cruickshank, Morris Brown   +2 more
exaly  

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

Lancet, The, 2019
Rajiv Agarwal, William B White
exaly  

Spironolactone

2002
B ALHADIYA, F BELAL, Y ASIRI, O GUBARA
openaire   +1 more source

Spironolactone

Reactions Weekly, 1992
openaire   +2 more sources

Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety

Journal of Hepatology, 2003
Maria Luisa Granada, Quintero E, Ramon Planas   +2 more
exaly  

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study

British Journal of Clinical Pharmacology, 2017
Thomas Macdonald, Li Wei, Isla Mackenzie   +2 more
exaly  

Spironolactone

Reactions Weekly, 2003
openaire   +1 more source